Skip to content

Association of Clinical Scientists

  • Home
  • Information
  • Officers &
    Committees
  • Membership
  • Annual Meeting
  • Awards &
    Lectureships
  • Annals of Clinical &
    Laboratory Science
  • News
  • Introduction

  • Program

  • Abstract Instructions

  • CME

  • Registration

  • Accommodations


  • Future Meetings


  • Archive of Past Meetings

  • Chronology of Past Meetings

Introduction

The 132nd Meeting of the Association of Clinical Scientists will be held in Mobile, Alabama, from Wednesday, 23 May, to Sunday, 27 May 2012. The headquarters will be the Renaissance Mobile Riverview Plaza Hotel, located in downtown Mobile. The meeting, with a theme of Advances in Pathology for Personalized Medicine, will be hosted by the University of South Alabama, School of Medicine, where one of the meeting sessions will be conducted. Drs. J. Allan Tucker and Jacek Polski, Co-(Chairs of the Program Committee, cordially invite you to attend.

Details of the meeting program can be found in the next section.

Program

Wednesday, 23 May (Riverview Plaza Hotel)

2:00 pm Meeting registration desk opens

2:30 pm Educational Accreditation Committee meeting

3:30 pm Executive Committee meeting

5:00 pm Editorial Board meeting

7:45 pm Executive Committee meeting with Past-Presidents, Regional Delegates, and Committee Chairs


Thursday, 24 May (Riverview Plaza Hotel)

Session A
Advances in Pathology for Personalized Medicine
(Chairs: Roland Valdes, Jr., & J. Allan Tucker)
 
8:00 am Welcome. Magali J. Fontaine, President of the Association; J. Allan Tucker and Jacek Polski, Co-(Chairs of Program Committee
 
8:05 am [1] Abraham J. Gitlitz Memorial Lecture: Challenges of smaller facilities in the changing world of medicine. J. Allan Tucker, Mobile, AL

8:35 am [2] POCT and molecular diagnostics: the future. Frederick L. Kiechle, Hollywood, FL

9:05 am [3] Personalized medicine in hematopathology. Jacek Polski, Mobile, AL

9:35 am [4] Personalized medicine: the current advances in diagnosis and treatment of mental illnesses. Tatiana Souslova, et al, Temple TX

10:05 am  Refreshments

Session B
Genomics, Proteomics, and Personalized Medicine
(Chairs: Robert E. Brown & Egil Fosslien)

10:20 am [5] Predictive markers in breast carcinoma. Andrea G. Kahn, Mobile, AL

10:50 am [6] Investigating Sirt1 in hepatocellular and cholangiocellular carcinomas. Consolato Sergi, et al, Alberta, Canada

11:20 am [7] Personalized medicine and therapy for chronic Hepatitis C: the role of IL28B genotyping. Patricia R. Slev, Salt Lake City, UT

11:35 am [8] ZBP-89 arrests the growth of hepatocellular carcinoma via targeting epigenetic enzymes. George G. Chen, Hong Kong

11:50 am Luncheon recess

Luncheon Sponsored by the Sections on Clinical Science in Practice and Clinical Molecular Biology and Genetics
(Chair: Magali J. Fontaine)

12:00 pm [9] Emerging role of pathologists in patient centered medical homes. Robert L. Hunter, et al, Houston, TX

Session C
Molecular and Cell Biology
(Chairs: Frederick L. Kiechle & Kyle C. Kurek)

1:05 pm [10] Homocysteine, thioretinamide, and the pathogenesis of cancer and arteriosclerosis. Kilmer S. McCully, Boston, MA

1:35 pm [11] Surfactant deficiency disorders: review of histopathologic, ultrastructural, and genetic features. John Hicks, Houston, TX

2:05 pm [12] Genetic discovery in rare disorders using archival pathology material. Kyle Kurek, Boston, MA

2:25 pm [13] Role of transforming growth factor-b signaling in gradient-induced hormetic morphogenesis, Egil Fosslien, Chicago, IL

2:45 pm [14] Hepatitis C genotype analysis: longitudinal review in a large veteran population. L. Brannon Thomas, et al, Tampa, FL

3:05 pm Refreshments

Session D
Oncology

(Chairs: Kilmer S. McCully & Steven I. Hajdu)

3:20 pm [15] Companion diagnostics: is it a reality? Kristen K. Reynolds et al, Louisville, KY

3:50 pm [16] Advances in cell separation technologies: isolation of circulating tumor cells. Lori M. Millner et al, Louisville, KY

4:20 pm [17] Epithelial-mesenchymal transition: morphoproteomics and systems biology provide diagnostic and individualized therapeutic options. Mary F. McGuire et al, Houston, TX

4:50 pm [18] Human factors engineering design of cancer protocols. Philip Foulis et al, Tampa, FL

5:05 pm [19] Morphoproteomic profiling of pediatric glioblastoma multiforms: biologic commonalities and therapeutic options. Kristine Konopka et al, Houston, TX

5:20 pm [20] Salinomycin induces cell death and reduces expression of stemness genes in human neuroblastoma cells with therapeutic potential in neural cancer stem cells.  Priya Weerasinghe et al, Houston, TX

5:35 pm Adjournment

7:30 pm Musicale rehearsal (organized by Myra L.Wilkerson)

7:30 pm Awards Committee meeting (Roland Valdes, Jr, Chair)

8:30 pm Nominating Committee meeting (Dani S. Zander, Chair)


Friday, 25 May (University of South Alabama)

(Bus leaves Hotel at 7:15 am)

Session E
Clinical Science in Practice
(Chairs: Magali J. Fontaine & Dani S. Zander)

8:00 am [21] Myb- a novel determinant of castration-resistance and aggressive phenotype in prostate cancer. Sanjeev K.Srivastava et al, Mobile, AL

8:15 am [22] Role of Heat Shock Factor-1 in mediating drug sensitivity in breast cancer. Shruti Desai et al, Mobile, AL

8:30 am [23] Post-translational regulation leads to loss of tumor suppressor Merlin in breast cancer. K. Adam Morrow et al, Mobile, AL

8:45 am [24] Understanding regulation of N-myc interactor; a novel regulator of breast malignancy. Jack W Rostas et al, Mobile, AL

9:00 am [25] Honokiol: A novel natural agent for pancreatic cancer prevention and therapy. Sumit Arora et al, Mobile, AL

9:15 am [26] Isolation, characterization and culture of cancer stem min cells for HTS compound screening. Steven McClellan et al, Mobile, AL

9:30 am [27] Bridging the gap: using patient simulation in medical education to improve practice. Michael Jacobs, Mobile, AL

9:45 am Refreshments

Session F
Workshop in Medical Education Simulation

10:15 am Simulation with robot controlled mannequins is revolutionizing medical education.  These three 30’ workshops will demonstrate three of the most valuable simulations with special relevance to clinical problems encountered in pathology. Participants will divide into three groups and rotate through all three simulations.

11:45 pm Bus returns to Riverview Plaza Hotel

12:45 pm Bus leaves Riverview Plaza Hotel for optional tour of Five Rivers Delta Resource Center (open to participants and accompanying persons).

4:45 pm Bus returns to Riverview Plaza Hotel

Annual Reception and Banquet
(6:15 pm Reception, 6:45 pm Banquet, Riverview Plaza Hotel)

Toastmaster: Magali J. Fontaine, Stanford, CA
 
Young Clinical Scientist Award presented by Charles D. Hawker to Kristen K. Reynolds, Louisville, KY
 
Diploma of Honor presented by Robert L. Hunter to Nina Tatevian, Houston, TX
 
Clinical Scientist of the Year Award presented by Roland Valdes, Jr, to Juliana Szakacs, Boston, MA
 
Banquet address: Frye Gaillard, Writer-in-Residence, University of South Alabama, author of several highly regarded books and the 2012 recipient of the prestigious Clarence Cason Award for Nonfiction Writing by the University of Alabama.


Saturday, 26 May (Riverview  Plaza Hotel)

(Sessions G & H are concurrent with Sessions I,  J, & K)

6:15 am Run-for-the Lilies: 2.5 and 5 mile running or walking event organized by Robert Hunter and Consolato Sergi for the Committee on Athletics

Session G
Cell and Tissue Pathology
(Chairs: Nina Tatevian & Peter F. Farmer)

8:00 am [28] Role of ultrastructural evaluation of peripheral blood in diagnosis of metabolic storage disease. John Hicks, Houston, TX

8:30 am [29] Overexpression of SPARC in uterine leiomyosarcoma and STUMP. Sadhna Dhingra et al, Houston, TX

8:45 am [30] Morphoproteomics/morphometrics defines dedifferentiation in liposarcoma and provides therapeutic options: a case study.  Erica Syklawer et al, Houston, TX

9:00 am [31] Breast carcinoma predictive markers: correlation between core biopsy and excision specimens. Oscar Roncal et al, Mobile, AL

9:15 am [32] High grade adenocarcinoma presenting as a vulvar metastasis. Amanda Tchakarov et al, Houston, TX

9:30 am [33] Intravascular large B-cell lymphoma: current concepts with a case report. Troy Davis et al, Louisville, KY

9:45 am [34] Breast carcinoma metastasis to the placenta. Alyaa Al-Ibraheemi et al, Houston, TX
10:00 am Refreshments

Session H
Slide Seminar: Anatomic Pathology
(Chairs: Joseph Parker & Jacek Polski)

10:15 am [35] Pulmonary blastoma: a case report and review of the literature. Crystal Cordell et al, Mobile, AL

10:30 am [36] A case report of fatal meningoencephalomyelitis due to Halicephalobus sp. Bhavesh Papadi et al, Mobile, AL

10:45 am [37] Metastatic myxoid chondrosarcoma to the lung: a diagnostic dilemma. Kelly E. Moses et al, Mobile, AL

11:00 am [38] A case of angiolymphoid hyperplasia with eosinophilia: a neoplasm or reactive process? Rocky Adams et al, Mobile, AL

11:15 am [39] Interdisciplinary approach in the diagnosis of hematologic malignancies. Dalia A Azim et al, Mobile, AL

12:00 pm Luncheon recess (see Luncheon presentation, listed after Session K)

Session I
Clinical Immunology and Microbiology
(Chairs: Charles D. Hawker & Consolato Sergi)

8:00 am [40] Interpretation of anti-HLA antibodies detected by fluorescence techniques for organ transplantation. Terry O Harville, Little Rock, AR

8:30 am [41] Recurrent meningitis due to multiple enteric organisms: etiology and management strategy. Modushudan Bhattacharjee et al, Houston, TX

8:45 am [42] Molecular diagnosis of infectious diseases. Ioan Cucoranu, Mobile, AL

Session J
Therapeutics and Toxicology
(Chairs: Donald Cannon and Sidney M. Hopfer)

9:05 am [44] Urine drug testing: a form of medication reconciliation in patients with pain. Amadeo J. Pesce et al, San Diego, CA

9:25 am [45] Pharmacogenomic economics. Jonathan S Krauss, Augusta GA

9:45 am [46] Everolimus method comparison between Waters MassTrak™ XE (IUO) Kit and LC-MS/MS method. Kamisha L. Johnson-Davis, Salt Lake City, UT

10:00 am Refreshments

Session K
Clinical Biochemistry and Biotechnology
(Chairs: Roger Bertholf & Joshua A. Bornhorst)

10:15 am [47] Pre-analytical stability of serum markers for multiple myeloma.  Joshua Bornhorst et al, Little Rock, AR

10:45 am [48] Lamellar body counts on a Sysmex 5000 hematology analyzer: comparison to the Abbott FLM. Roger Bertholf, Jacksonville, FL

11:00 am [49] Clinically silent massive fetomaternal hemorrhage revealed by the Kleihauer-Betke (KB) test. Ginell R. Post et al, Charleston, SC

11:15 am [50] Development and implementation of a high throughput screen for small molecules that reverse MRP-1 mediated multi-drug resistance. Adam B. Keeton, Mobile, AL

11:30 am [51] Pituitary adenoma subclassification using a quantitative multiplexed immunoassay. Frederick G. Strathmann et al, Seattle, WA

11:45 am [52] Inaccuracy of indirect argatroban quantitation in certain clinical conditions. Jeanne M. Rhea et al, Atlanta, GA

12:00 pm Luncheon recess

Luncheon sponsored by the Section on
Clinical Science in Practice
Chair: Philip R. Foulis
12:10 pm [53] Art history: the ongoing utility of electron microscopy.  J. Allan Tucker , Mobile, AL
1:10 pm adjournment

Session L
Clinical Informatics
(Chairs: Myra L. Wilkerson & Sriram Iyengar)

1:15pm [54] Pathology informatics, bioinformatics, and personalized medicine. Ioan Cucoranu, Mobile, AL

1:45 pm [55] Validation of an automated camera system to identify patient name mislabeled specimens. Charles D. Hawker, Salt Lake City, UT

2:00 pm [56] Is it time for delta checks to “check out”? Frederick G. Strathmann et al, Seattle, WA

2:15 pm [57] QAZoom: a software tool for tracking cervical cytology workload and diagnostic rates by preparation type. Myra   L. Wilkerson, Wilkes-Barre, PA

Session L
Clinical Informatics
(Chairs: Myra L. Wilkerson & Sriram Iyengar)

1:15pm [54] Pathology informatics, bioinformatics, and personalized medicine. Ioan Cucoranu, Mobile, AL

1:45 pm [55] Validation of an automated camera system to identify patient name mislabeled specimens. Charles D. Hawker, Salt Lake City, UT

2:00 pm [56] Is it time for delta checks to “check out”? Frederick G. Strathmann et al, Seattle, WA

2:15 pm [57] QAZoom: a software tool for tracking cervical cytology workload and diagnostic rates by preparation type. Myra   L. Wilkerson, Wilkes-Barre, PA

Session N
Hematology and Transfusion Medicine
(Chairs: Magali J. Fontaine & John Lazarchick)

3:45 pm [61] Racial/ethnic disparity in the control of hypertension after non-traumatic subarachnoid hemorrhage. Richard Baltaro et al, Omaha, NE

4:00 pm [62] Preventing allergic transfusion reactions. Magali J Fontaine et al, Stanford, CA

4:15 pm [63] Acquired Factor X deficiency secondary to AL amyloidosis. John Lazarchick, Charleston, SC

4:30 pm [64] Probable drug-induced hemolytic anemia masquerading as Brown Recluse spider bite envenomation. Eric Rosenbaum et al, Little Rock, AR

4:45 pm Session adjourns

4:50 pm Business Meeting of the Association Magali J. Fontaine, President

Association Musicale and Art Show
(Riverview Plaza Hotel - 7:30 pm)

with wine and cheese reception during intermission.
Organized by Myra L. Wilkerson, Chair of the Committee on Music and Fine Arts

Abstract Instructions

The deadline for abstract submission has passed and abstracts can no longer be accepted.

Continuing Education (CME and CE)

Accreditation. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the College of American Pathologists (CAP) and the Association of Clinical Scientists. The College of American Pathologists is accredited by the ACCME to provide continuing medical education for physicians.

Continuing Medical Education Designation (CME). The College of American Pathologists designates this live educational activity for a maximum of 20.00 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Continuing Education (CE) for Non-physicians Designation. The College of American Pathologists designates this live educational activity for a maximum of 20.00 credit hours of continuing education. Participants should claim only credit hours commensurate with the extent of their participation in the activity.

ASCP Statement. This activity is acceptable to meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program.

California and Florida Statement. This activity is approved for continuing education credit in California and Florida. Florida non-physicians must provide their license numbers.

Disclaimer. The content of this CME activity does not necessarily reflect the view or policies of the College of American Pathologists.

Educational Goals. At the end of this educational session the participant should be able to
(a) Interpret, discuss, appraise, and apply in the clinical arena various recent advances in laboratory techniques for clinical diagnosis and knowledge about clinical science, including clinical biochemistry, immunology, microbiology, hematology, transfusion medicine, toxicology, cell and tissue pathology, informatics, molecular biology and biotechnology.
(b) Survey the frontiers of research in clinical science, emphasizing transfusion medicine, hematology, molecular biology, atherosclerosis, instrumental analysis, microbiology, and anatomic pathology.
(c) Analyze the molecular circuitry of cancer cells by examining the expression patterns of specific proteins using immuno-histochemical techniques, and apply this information to predict the therapeutic responses of individual tumors to modulators of gene expression.

Educational Needs. Specific educational needs of the target audience include: (a) technical and diagnostic integration of morphoproteomics for surgical pathology and appropriate selection of clinical therapeutic models; (b) methods for consultative integration of pharmacogenomic data for personalized medical care; (c) alternative models and methods for metabolic profiling in toxicology; (d) methods for improving safety and specimen integrity using automation in the clinical laboratory.

Professonal Practice Gaps. Four professional practice gaps are the primary targets of this program: (a) disparity between the state-of-the-art in cancer morphoproteomics and the availability of immunohistochemical profiling of the morphoproteomic patterns of each cancer patient’s tumor, to guide individual selection of optimal cancer therapy; (b) disparity between current practices in laboratory medicine and new clinical approaches to individualization or personalization of laboratory tests, especially in respect to pharmacogenomics; (c) disparity in current laboratory practices in toxicology and state of the art metabolic profiling; (d) disparity in state of the art automation with use of delta checks and barcodes and safety in the current laboratory work flow.

Evidence-based Recommendations. The College of American Pathologists and the Association of Clinical Scientists are dedicated to promoting improvements of quality in healthcare and not a specific proprietary business interest or a commercial interest. Therefore the College of American Pathologists and the Association of Clinical Scientists expect all planners/faculty/authors of these educational activities to make all recommendations and/or planning criteria involving clinical medicine to be based on evidence that is accepted within the profession of medicine as adequate justification for these indications and contraindications in the care of patients.

Methods and Evaluation. This program will use lectures, case discussions, a technical workshop, a tutorial session, and question-and-answer opportunities as primary educational methods. A course evaluation form will provide participants with the opportunity to assess each session and speaker, to identify future educational needs, and to comment on any perceived commercial bias in the presentations.

Disclosure Statements. All faculty, planners, and authors of a CAP educational activity must disclose to the program audience any financial interest or relationship with the manufacturer(s) of any commercial product(s) that may be discussed in the educational activity or with the manufacturer of a product that is directly competitive with a product discussed in the presentation. Relevant financial relationships are considered to be any financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

The College of American Pathologists does not view the existence of these interests or uses as implying bias or decreasing the value to participants. The CAP, along with the Accreditation Council for Continuing Medical Education (ACCME), feels that this disclosure is important for the participants to form their own judgments about each presentation. The program contains a list of the financial disclosure relationships for anyone who was able to affect content of this educational activity. The CAP does identify and manage all potential conflicts of interest to ensure that all educational activities promote improvements or quality in healthcare and are free of commercial bias for or against a product/service.

Registration

The regular registration fee is $435. Junior members, emeritus members, and non-member residents or post-doctoral fellows may pay a reduced fee ($295). The registration fee includes one ticket to the reception and banquet on Friday evening. Tickets for the luncheons of scientific sections cost $30. Admission to the musicale and art show on Saturday evening is free. Please download the meeting registration form, fill it out, and send it by fax or regular mail to 6431 Fannin, MSB2.292 Houston, TX 77030.

Register Online for Annual Meeting

Accommodations & Transportation

Hotel Accommodations

The Renaissance Mobile Riverview Plaza Hotel is the headquarters hotel for the meeting and most activities. This AAA 4-Diamond hotel features the Harbor Room restaurant open for breakfast, lunch, and dinner, the Fathoms Lounge open for light dinners (tapas) and which has covered outdoor seating, a fitness center, and an outdoor swimming pool. The hotel is also connected to the Arthur R. Outlaw Convention Center and is near the Mobile entertainment district and museums. It is also near the Robert Trent Jones Golf Trail with 54 championship holes at Magnolia Grove (17 miles) and is 35 miles from the Gulf Shores Alabama beaches. The special convention rate will be $129/room (single or double) plus taxes. Currently, the tax rate is 14%. The hotel's address is 64 South Water Street, Mobile, Alabama 36602 (click here to access its website). The number of available rooms at the convention rate is limited, so you should make your reservations early by calling the hotel at (251) 438-4000, or toll-free (800) 922-3298, or by sending a fax to (251) 415-0123. Please specify that you will attend the Association's meeting in order to receive the meeting rate and enable the Association to meet its contracted number of rooms. The cut-off date for reservations at the special convention rate is 23 April 2012.

Transportation

The Renaissance Mobile Riverview Plaza Hotel does not provide shuttle service to either the Mobile, AL (MOB) Airport (14 miles), the Pensacola, FL (PNS) Airport (57 miles), or the Biloxi, MS (GPT) Airport (72 miles). In addition to rental cars, alternate transportation options from MOB are taxi cab (~$46 one way) or Mobile Bay Transportation (251-633-5693, www.mobilebaytransportation.com) ($20 one way). Mobile Bay Transportation also serves the PNS ($125 one way) and GPT airports ($128 one way). Advance reservations are required. On-site parking at the hotel is $12 per day or $17 per day for valet parking.

Future Meetings

2013

(May 15 - 19) Boston, Massachusetts. Dr. Juliana Szakacs will be the Meeting Chairperson.

2014

Amelia Island, Florida, hosted by University of Florida, Jacksonville. Dr. Roger Bertholf, Meeting Chairperson.

2015

Park City, Utah, hosted by University of Utah School of Medicine and ARUP Laboratories. Dr. Charles D. Hawker, Meeting Chairperson.

Archive of Past Meetings

Highlights of 131st Meeting, Louisville, Kentucky May 18-22, 2011



In Memory of F. William Sunderman, Jr., MD, (June 23, 1931 – April 1, 2011)

The 131st meeting of the Association of Clinical Scientists was held in memory of Bill Sunderman, Jr., who served the Association for 42 years as Secretary-Treasurer, as Editor-in-Chief of the Annals of Clinical and Laboratory Science, and in numerous other capacities.

F. William Sunderman Jr. (Bill), who died on April 1, 2011 at the age of seventy-nine was, like his illustrious father of the same name, a physician and scientist, both of whom made many significant contributions to the field of laboratory medicine and especially the sub-specialty of nickel toxicology. Both father and son were devoted servants of the Association of Clinical Scientists as founders, scientific meeting organizers and editors of the Annals of Clinical and Laboratory Science. Bill was born in Philadelphia, Pennsylvania on June 23, 1931. He graduated as valedictorian from Central High School in Philadelphia in 1948 and with a BS degree from Emory University in Atlanta in 1952. He underwent his medical training at Thomas Jefferson University in Philadelphia where he obtained the M.D degree in 1955. From 1955 to 1956 he was an intern at Thomas Jefferson University and from 1956-58 a fellow in metabolic research at the same location. It was at this time that Bill considered specializing in nephrology but the depressing nature of this field before hemodialysis treatment was developed discouraged him and he entered the same field as his father namely clinical pathology. His first foray was as the Chief of the Clinical Chemistry Service at the US Naval Medical School in Bethesda Maryland from 1958-60. At this time He was a lieutenant in the US Navy. It is evident that Bill’s primary interest was in clinical chemistry since his first publications beginning with “The clinical significance of measurements of protein-bound iodine (1954)” could all be classified as belonging to this discipline. Following a spell (1961-64) as Instuctor in Medicine, Thomas Jefferson University, Philadelphia, Bill took on even more onerous service and academic responsibility by moving to the Department of Pathology at the University of Florida in Gainesville, Florida where he was Director of Clinical Laboratories and Associate Professor of Pathology. The Shands Teaching Hospital at the University of Florida opened just six years before Bill’s arrival but already had an excellent tradition in clinical pathology since the first director of laboratories was Dr. John Bernard Henry, a distinguished pathologist who went on to make many significant contributions. Bill fitted well into the clinical laboratory and put together an excellent staff of faculty and technical experts. One change that he did make, however, was brought about when the processing of a seventy-two hour fecal fat specimen which required homogenization on a paint can shaker. The container’s lid came loose during the shaking process resulting in an environmental disaster throughout the clinical laboratory. Thereafter, Bill decreed that the processing should take place in a more remote and contained place. Bill exhibited considerable administrative skills in directing and developing the clinical laboratory services. He initiated the development of one of the first clinical laboratory computer systems complete with cumulative reporting and, for the first time, the application of delta checking of results. He also was interested in developing more sophisticated analytical techniques, something that was part of his legacy for the next four decades. However, it was the creation of a research program in concert with his service and teaching skills that shaped the start of his academic career in a leadership position. Bill was well funded by the American Cancer Society and his laboratory focused on nickel carcinogenesis. He was remarkably creative: he had, as aptly stated by his department chairman Dr. Joshua Edwards, “the ability to shed ideas like water off a duck’s back”. A steady stream of papers came out of his laboratory creating new avenues of research. Bill was also a gifted teacher and his lectures, especially those presented to the medical students were well-organized, well-prepared and well-received by his audience. Throughout his life Bill had little interest in sports but he did attend the University of Florida football games, probably because he lived just across the street from Florida Field, the home of the Fighting Gators. Bill’s wife, Carolyn, came to the University of Florida as a resident in pediatrics and they resided in a lovely comfortable home near the university and it was here that their first child was born. It was also at the University of Florida that Bill was starting to attract students to his laboratory, many from outside the United States. This continued in his later career and many distinguished medical scientists from countries around the world, including Poland, Yugoslavia, Japan and many others spent time in Bill’s laboratory and took their knowledge acquired there to establish their own research programs.

In 1968, after achieving the academic rank of full professor and having established himself as an internationally recognized leader in laboratory medicine, Bill decided to move on to the next step: that of department Chair. He received several offers, some from well-established programs, but eventually decided on a newly established medical school in Farmington, Connecticut as part of the University of Connecticut. His position would be as chairman of the department of laboratory medicine, one of the few departments at that time to be separate from the department of pathology. He also was given a joint appointment as professor of pharmacology. Bill’s rationale reasoned that in becoming head of a new department in a new medical school he could form and shape it according to his own vision; what developed would depend largely on his leadership. He went to Farmington inheriting no “baggage”. He also felt that a smaller hospital, as the Shands Teaching Hospital in Florida was during his tenure there, minimized his time spent on administrative duties providing more time for research and other academic activities. At the time of his arrival exchanging the colder climes of New England from the warmth of Florida, the new hospital and medical school in Farmington was just a large hole in the ground. His clinical and research laboratories were situated at the McCook Hospital in Hartford. Eventually the new facility was complete and Bill spent the next twenty-nine years directing a vibrant and productive program. He was now in his prime. His research developed along new lines of investigation, as is the case with all research programs, but the main focus was on the chemical toxicology and clinical chemistry of metals with nickel, of course, being the primary metal of interest. Bill maintained a high and consistent level of funding from The National Institutes of Health, The American Cancer Society, The United States Department of Energy, The Environmental Protection Agency and others throughout his career during which he published two hundred and fifty-eight articles in refereed journals, eighty-seven articles in monographs, manuals and texts, and eighteen books. As he told his junior faculty and students, “Publications are the best form of insurance for the academician”.

Almost all energetic, ambitious and successful scientists eventually become involved in national and international scientific organizations. For many years (1972-1988), Bill focused his considerable degree of energy on the International Union of Pure and Applied Chemistry (IUPAC), Clinical Chemistry Division. His efforts were mainly directed towards the Commission on Toxicology and its various subcommittees particularly the Nickel Subcommittee. The international nature of IUPAC provided Bill with the opportunity to travel and to apply his scientific and organizational skills worldwide. The Commission on Toxicology held their first international meeting in Monte Carlo in 1977 with, and under Bill’s leadership, it enjoyed considerable success. Many other meetings followed including several of the Nickel Subcommittee which was well supported by the nickel-producing industry. The well-known problem of nickel carcinogenesis in nickel-producing workers was of concern to the industry and Bill’s efforts added greatly to the understanding and prevention of this devastating problem in these workers. It was at the last IUPAC meeting that Bill helped to organize that his skills and knowledge were so evident. With his usual talent he planned the scientific program putting together a cohesive schedule that would not be instinctive to most people but which was second nature to Bill. The conference was in Vancouver, Canada and when the time came for him to present his own paper he was asked a question during the discussion period as to the pH of some reagent. He immediately gave the correct answer to two decimal places demonstrating his comprehensive knowledge of the experiments that had been carried out in his laboratory. Bill’s involvement in IUPAC inspired many young scientists and allowed him to interact with people who were working in fields different from his own. He was also involved in other international organizations including the International Federation of Clinical Chemistry, International Commission on Occupational Health and others, but none occupied his energies as much as IUPAC. This International involvement allowed Bill to interact with scientists around the world, creating an aura of good fellowship that he cherished.

Bill gave a lifetime of service to the Association of Clinical Scientists which had been founded by his father. He served as president 1964-65 and in 1969 upon the death of Dr. Bob McFate, he took over as secretary-treasurer; Bill held this position until his own death. On top of these burdensome duties, in 1999 he added those of editor-in-chief of the Annals of Clinical and Laboratory Science again holding this position until his death. He took over from his father, the first editor who decided to “take a breather” at the age of 101. Bill played a major role in the planning and organization of the Association meetings and always did an on-site visit in order to work with the local committee. He always put together the finishing touches making sure that the meeting rooms were wide and spacious rather than long and narrow, and that the meals and refreshments were appealing but not extravagant. The scientific program was his specialty and, as stated earlier, he had a knack of putting together cohesive sessions and would bracket a speaker “of limited ability” with a couple of excellent presentations. (He learned this trick from his Father of course.) Bill was always kind to speakers especially to young clinical scientists embarking on their careers. He would remark “Wonderful paper and great presentation – your best ever” to inspire confidence in those unsure of their abilities.

Bill always was a key performer in the Musicale, since the early 1970s a feature of the Association meetings. Many of us have fond memories of Bill, his father and a few other highly talented musicians who were Association Members, entertaining us with accomplished performances of chamber music. Bill was a gifted violist having decided early in life not to follow his Father in everything. Bill Senior was a violinist who had the distinction of owning several wonderful instruments including a Stradivarius known as the Irish Strad. Bill Junior eventually inherited this violin, which he sold and used the proceeds to buy a really excellent viola, something he enjoyed immensely. The Arts, especially chamber music, were most important to Bill, and provided a means of bonding with his professional and social friends and family. He will be intensely missed by a remarkable diversity of friends. Many of these friends bonded with Bill and his family through weekly evenings of chamber music. These sessions were typically followed by convivial and uplifting conversation.

Bill achieved many awards throughout his career, the major ones being as follows: The Ames Award for Outstanding Contributions to Clinical Chemistry from the American Association for Clinical Chemistry (1978); Clinical Scientist of the Year (1976), Recipient of Gold Headed Cane (1998) and Diploma of Honor for Outstanding Contributions to Clinical Science (2007) from the Association of Clinical Scientists; Achievement Award for Research on Nickel Toxicology (1992) and Chemistry and Human Health Division Award for Leadership Clinical Chemistry and Toxicology (2010) from IUPAC.

Bill retired from the Chair of Laboratory Medicine at the University of Connecticut in 1997 and he and his wife Carolyn moved to Whiting, Vermont. In his retirement he was a research professor of pathology at the University of Vermont, and a visiting scholar in chemistry and biochemistry at Middlebury College while continuing his extensive duties for the Association of Clinical Scientists.

From the 1970s onwards, Bill and Carolyn always had owned a series of Labrador Retrievers each of which he adored. The first one was acquired at an Association meeting in Washington and came from a noted breeder in Middleburg, Virginia; the contact being made by this writer.

Bill's beloved wife, Carolyn predeceased him in 2002. His brother, Joel Baily Sunderman, and sister, Louise Lehr Sunderman also predeceased him. He is survived by his daughter and son-in-law, Emily L. Sunderman and Michael J. Lee, of Cornwall; daughter and son-in-law, Elizabeth R. Sunderman and Robert C. Hauck of Salt Lake City, Utah; son and daughter-in-law, Frederick W. Sunderman III and Kathleen L. Sunderman of Freeland, Michigan; mother-inlaw, Frances L. Reynolds of Chestertown, Maryland; grandson, Carter S. Lee of Cornwall; granddaughters, Hailey L. and Caitlin E. Hauck of Salt Lake City; grandson, F. William Sunderman IV, and granddaughter, Chloe E. Sunderman of Freeland, Michigan.

Dr. F. William Sunderman Jr. was much loved by his family, friends, colleagues and many in the scientific community. He was kind, helpful and full of encouragement and had a broad range of interests and talents. We can hope but not expect to see his like again.

John Savory,
Charlottesville, Virginia


Claude P. Brown Memorial Lecture

James L. Wittliff, Ph. D., M.D. hc, FACB: Deciphering the genomics and proteomics of human cancer to predict clinical behavior.

Professor Wittliff’s team is internationally regarded for studies of estrogens and their mimics with receptor proteins in human cancer, exploiting proteomics and genomics. His laboratory was among the first to report estrogen receptors in a breast cancer biopsy predicted a patient’s response to hormone therapy. This finding led to collaborations with the NSABP, establishing Tamoxifen as adjuvant therapy for breast cancer and use of receptors as biomarkers of patient prognosis and response. With NEN/DuPont, Dr. Wittliff developed the original FDA-approved kits for assessing estrogen and progestin receptors in biopsies, celebrated as a major contribution to laboratory medicine. His laboratory, designated the National Reference Facility for historical clinical trials in North America, served more than 400 laboratories worldwide. Focusing expertise on molecules exhibiting estrogen mimicry, Dr. Wittliff and IA, Inc. patented receptor-based biosensors detecting endocrine-disrupting compounds in the environment. Awards include Outstanding Contributions to Clinical Chemistry from the AACC, Goldsmith Research Excellence Award from the American Cancer Society and the University of Louisville President's Award for Career Achievements. More than 200 students and research fellows from 45 countries have trained in his laboratory. Currently Dr. Wittliff directs the Institute for Molecular Diversity & Drug Design, which he co-founded.


Clinical Scientist of the Year Award

Presented to Roland Valdes, Jr., PhD by Magali Fontaine, MD, PhD

Dr. Valdes is Professor and Senior Vice-Chairman in the Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine. He is also Professor of Biochemistry and Molecular Biology, serves as Chief of Clinical Chemistry and Toxicology and is the founder and director of a Postdoctoral Fellowship Program in Clinical Chemistry in the Department of Pathology and Laboratory Medicine. Dr. Valdes is nationally and internationally recognized as a leader in advancing the profession of clinical chemistry through his major contributions in promoting clinical chemistry as a discipline via the scholarships of clinical service, research, and teaching. As a result of these activities, Dr. Valdes has played a major role in heading and participating in numerous national committees and in leading several of our key professional organizations. He has served as president of the Clinical Ligand Assay Society (CLAS), president of the National Academy of Clinical Biochemistry (NACB), and is a past-president of the Commission for Accreditation in Clinical Chemistry (ComACC). Dr. Valdes has also served on the Board of Directors of the American Association for Clinical Chemistry (AACC) and as a director on the American Board of Clinical Chemistry (ABCC). Additionally, Dr. Valdes has been engaged in many other national work groups including federal government advisory committees. His scientific interests involve discovery and characterization of the mammalian cardenolides and their pathophysiologic role in cardiovascular disease and, more recently, in cancer therapeutics. For this scientific work, he has been awarded numerous grants from the NIH and other public and private organizations as well as several distinguished scientist awards from professional organizations such as the NACB, the CLAS, and the ACS. Dr. Valdes has authored more than 250 publications. In addition to his other research laboratories, Dr. Valdes is the principle founder and President of the Pharmacogenetics Diagnostic Laboratory at the University of Louisville where he is currently working on transitioning the science of pharmacogenetics and proteomics into clinical laboratory practice.


Diploma of Honor

Presented to Charles D. Hawker, PhD, MBA by Robert L. Hunter, Jr., MD, PhD

Dr. Charles Hawker is Scientific Director for Automation and Special Projects at ARUP, where he has been for 19 years. Dr. Hawker is also Professor (Adjunct) of Pathology in the University of Utah, School of Medicine. Previously, over a twenty year period, he held various positions in research and development and management at Laboratory Procedures, Inc. (Upjohn) and SmithKline Beecham Clinical Labs. At ARUP he has installed several major automation and robotic systems that have made ARUP one of the country’s most automated laboratories. He is a past president of the Association of Clinical Scientists, the National Academy of Clinical Biochemistry (NACB), and the Clinical Ligand Assay Society (CLAS). He has received the John V. Bergen Award of the Clinical and Laboratory Standards Institute (CLSI), the Professor Alvin Dubin Award from the NACB, and the Becton Dickinson Award from the Association for Laboratory Automation.

He has chaired automation committees in both CLSI and Health Level 7 and recently chaired the CLSI Subcommittee on Specimen Labels: Content and Location, Fonts, and Label Orientation. He is a co-author or author of four book chapters on clinical laboratory automation and a frequent lecturer on laboratory automation to national and international audiences. He has three issued patents and has published 40 peer-reviewed papers, 13 book chapters or invited reviews, and 42 abstracts. His most recent research efforts have focused on the use of machine vision systems for automated quality inspection of clinical laboratory specimens, particularly the development of an automated camera system that uses optical character verification (OCV) to identify mislabeled specimens.


Young Clinical Scientist of the Year Award

Presented to Peter C. Hu, PhD by Armand B. Glassman, MD

Dr. Peter Hu is an Associate Professor in the School of Health Professions (SHP) and is Director for the Molecular Genetic Technology Program. He received his Bachelor’s degree from Purdue University in 1990 with a major in Psychology and a minor in Chemistry. He later received his Master’s degree from Lamar University majoring in Microbiology and subsequently a Doctor of Philosophy from Trident University International (TUI) Healthcare Administration and Molecular Genetics. Dr. Hu also holds 3 specialty clinical certifications in Molecular Biology, Cytogenetics, and Clinical Laboratory Science. He joined MD Anderson Cancer Center (MDACC) in1995 and has worked in both clinical and academic environments.

Dr. Hu was a founding faculty member in the SHP and played an important role in MDACC achieving degree granting status by the Texas Coordinating Board in 2002, the Southern Association for Colleges and Schools (SACS) accreditation in 2005, the addition of the junior year curriculum approval in 2008, and SACS reaffirmation in 2010. He was also instrumental in the approval of the Molecular Genetic Technology program by the Texas Coordinating Board in 2005 and the program’s professional accreditation by the National Accrediting Agency for Clinical Laboratory Sciences (NAACLS) in 2005 and its reaffirmation in 2010.

Dr. Hu has taught over 28 courses within the SHP and has served or is currently serving as Chair or as member on 38 institutional committees. Dr. Hu has published over 100 abstracts, 17 papers, and 1 book chapter. He is on the editorial board for 3 journals and a column editor for another. He has received 41 recognitions and awards including the recent Young Clinical Scientist award from the Association of Clinical Scientists for his presentation on using saliva cells to detect microsatellite instability in hereditary non-polyposis colon cancer patients and their at-risk family members . Professionally, he has served as the President for Texas Association for Clinical Laboratory Science, Education Director and Chair of the Genetics Educators Committee for the Association for Genetic Technologist, Chair of the Molecular Scientific Assembly, Continuing Education Approval Committee, and Awards Subcommittee Chair for the American Society for Clinical Laboratory Science, a member of the Review Committee for Accredited Programs under NAACLS, and has served as a clinical laboratory science programs inspector for 10 year. Dr. Hu regularly presents at state, national, and international levels on topics dealing with genetics research, clinical laboratory sciences, and education.

Chronology of Previous Association Meetings

1. Sept 8, 1954; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Clinical Hemoglobinometry)

2. Nov 19-20, 1954; Bellevue-Stratford Hotel; Jefferson Medical College; Philadelphia, PA

3. April 1-2, 1955; Kenmore Hotel; Harvard Medical School; New England Deaconess Hospital; Boston, MA

4. Oct 7-8, 1955; Shoreham Hotel, Washington, DC: US Naval Medical Center, Bethesda, MD (Workshop on Blood Glucose)

5. Dec 9-10, 1955; Drake Hotel; University of Chicago, Argonne Cancer Research Hospital; Chicago, IL

6. April 6-7, 1956; Raleigh Hotel; Arlington Hospital; Washington, DC (Adoption of Constitution)

7. Oct 5-6, 1956; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Serum Proteins)

8. Dec 7-8, 1956; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

9. March 1-2, 1957; Sheraton Hotel; Northwestern University Medical School; Chicago, IL

10. July 15, 1957; Royal Army Medical College, London, UK (International Workshop on Hemoglobinometry)

11. Sept 27-28, 1957; Shoreham Hotel, Washington, DC; US Naval Medical Center, Bethesda, MD (Workshop on Serum Cations)

12. Dec 13-15, 1957; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

13. May 9-11, 1958; Sheraton-Lincoln Hotel; Indianapolis General Hospital; Eli Lilly Co; Indianapolis, IN

14. Oct 10-12, 1958; Park-Sheraton Hotel; New York, NY

15. Feb 26-Mar 1, 1959; Holiday Inn; Mobile Infirmary; Mobile, AL

16. Oct 9-11, 1959; Sheraton-Park Hotel; Washington Hospital Center; Washington, DC

17. March 3-5, 1960; DeWitt Clinton Hotel; Wadsworth Laboratory of NY State Health Department; Albany, NY

18. Nov 4-6, 1960; Shoreham Hotel; Washington Hospital Center; Washington, DC (Exocrine and Endocrine Functions of the Pancreas)

19. April 14-16, 1961; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA

20. Oct 27-29, 1961; Shoreham Hotel; Washington Hospital Center; Washington, DC (Thyroid and Parathyroid Functions)

21. April 6-8, 1962; Sheraton Hotel; Northwestern University Medical School; Chicago, IL

22. Oct 25-28, 1962; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Hemoglobin, its Precursors and Metabolites)

23. April 25-28, 1963; Sheraton Hotel; Louisville Medico-Chirugical Society; Louisville, KY

24. Oct 24-27, 1963; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Serum Proteins and the Dysproteinemias)

25. May 1-3, 1964; Bellevue-Stratford Hotel; Jefferson Medical College; Philadelphia, PA

26. Nov 13-15, 1964; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of the Serum Electrolytes)

27. April 29-May 2, 1965; Statler-Hilton Hotel; St. Albans Naval Hospital; New York, NY

28. Nov 11-14, 1965; Statler-Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of Infancy)

29. April 29-May 1, 1966; Palmer House; Chicago Board of Health Laboratories; Chicago, IL

30. Oct 20-23, 1966; International Inn; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Liver Diseases)

31. May 4-7, 1967; Robert Meyer Hotel, Orlando, FL; Kennedy Space Center, Cape Canaveral, FL; University of Florida College of Medicine, Gainesville, FL

32. Nov 2-5, 1967; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Kidney Diseases)

33. May 16-19, 1968; Peck Inn; University of Arkansas Medical School; Little Rock, AR

34. Nov 7-10, 1968; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Diseases Caused by Toxic Agents)

35. April 24-27, 1969; Malaga Inn; Mobile Infirmary; Mobile, AL

36. Nov 6-9, 1969; Mayflower Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Endocrine Disorders)

37. April 23-26, 1970; Ponchartrain Hotel; Wayne State University Medical School; Detroit, MI

38. Nov 6-8, 1970; Shoreham Hotel; Washington Hospital Center; Washington, DC (Chemical Hematology)

39. April 22-25, 1971; Hotel Sonesta; University of Connecticut Medical School; Hartford, CT

40. Nov 11-14, 1971; Hilton Hotel; Washington Hospital Center; Washington, DC (Clinical Pathology of the Serum Lipids)

41. April 27-30, 1972; Holiday Inn; Notre Dame University; Ames Co; Elkhart, IN

42. Nov 2-5, 1972; Marriott Motor Hotel; Northwestern University Medical School; Chicago, IL (Clinical Pathology of Respiratory Diseases)

43. May 3-5, 1973; Hawaiian Village Motel; St Joseph’s Hospital; University of South Florida College of Medicine; Tampa, FL

44. Nov 2-4, 1973; Shoreham Hotel; Washington Hospital Center; Washington, DC (Laboratory Diagnosis of Cancer)

45. March 7-10, 1974; La Jolla Village Inn; Scripps Foundation; University of California Medical School; La Jolla, CA

46. Nov 8-10, 1974; Bellevue-Stratford Hotel; Thomas Jefferson Medical College; Philadelphia, PA (Laboratory Diagnosis of Skeletal, Muscular, and Neurological Disorders)

47. May 2-4, 1975; Governors Inn; University of North Carolina Medical School; Chapel Hill, NC

48. Nov 7-9, 1975; Bellevue-Stratford Hotel; Thomas Jefferson Medical School; Philadelphia, PA (Laboratory Diagnosis and Monitoring of Disorders Caused by Drugs and Toxic Agents)

49. April 21-25, 1976; Hyatt Hotel; University of Puerto Rico Medical School; San Juan, PR

50. Nov 5-7, 1976; Shoreham Hotel, Washington, DC (Clinical Enzymology)

51. March 2-5, 1977; Congress Centre, Monte Carlo, Monaco (International Symposium on Clinical Chemistry and Chemical Toxicology of Metals)

52. April 28-May 1, 1977; Christopher Inn; Battelle Columbus Labs; Ohio State University School of Medicine; Columbus, OH

53. Nov 11-13, 1977; Drake Hotel, Northwestern University Medical School; Chicago, IL (Proteins and Proteinopathies)

54. May 4-7, 1978; Fairmont Hotel; University of California Medical School; San Francisco, CA

55. May 22-24, 1978; Caledonian Hotel; Falconbridge Nikkelwerk; Kristiansand, Norway (Kristiansand Conference on Nickel Toxicology)

56. Nov 3-5, 1978; Shoreham Hotel, Washington, DC (Clinical Pathology of Cancer of the Endocrine Glands and Target Organs)

57. May 3-6, 1979; Mills-Hyatt House; Medical University of South Carolina; Charleston, SC

58. Oct. 11-14, 1979; Benjamin Franklin Hotel; Jefferson Medical College; Philadelphia, PA (Biochemical Hematology)

59. May 8-11, 1980; Colonnade Hotel; Harvard Medical School; Boston, MA

60. Sept 3-5, 1980; Dragon Hotel; University College of Swansea; Swansea, Wales, United Kingdom (Swansea Conference on Nickel Toxicology)

61. Oct 31-Nov. 2, 1980; Drake Hotel, Chicago, IL (Laboratory Diagnosis and Monitoring of Disorders of the Kidney)

62. May 7-10, 1981; Bay Harbor Inn; St Joseph’s Hospital; University of South Florida College of Medicine; Tampa, FL

63. Oct 29-Nov 1, 1981; Barclay Hotel, Philadelphia, PA (Diagnosis of Disorders of the Fetus, Newborn, and Infant)

64. May 6-9, 1982; Sheraton-Miramar Hotel; UCLA Medical School; Beckman Instruments, Inc; Santa Monica, CA

65. June 17-20, 1982; Hotel Vier Jahreszeiten, Munich, Federal Republic of Germany (International Conference on Human Tumor Markers)

66. Nov 11-13, 1982; Drake Hotel, Chicago, IL (Laboratory Diagnosis and Monitoring of Cancer)

67. May 12-15, 1983; Boar’s Head Inn; University of Virginia Medical Center; Charlottesville, VA

68. July 19-22, 1983; Sheraton Centre, Montreal, Canada (Second International Conference on Clinical Chemistry and Chemical Toxicology of Metals)

69. Nov 10-13, 1983; Shoreham Hotel, Washington, DC (Clinical Pathology of Liver and Biliary Tract)

70. Feb 20-22, 1984; Hilton Hotel, Vienna, Austria (Second International Congress on Human Tumor Markers)

71. May 3-6, 1984; Hilton Hotel; University of South Alabama Medical School; Mobile, AL

72. Sept 4-7, 1984; PLM-St Jacques Hotel; Société Le Nickel; Paris, France (Nickel Metabolism and Toxicology)

73. Nov 15-18, 1984; Barclay Hotel, Philadelphia, PA (Clinical Pathology of the Reproductive Systems)

74. May 9-12, 1985; Sheraton-Islander Hotel; Brown University Medical School; Newport, RI

75. Oct 9-13, 1985; Galt House Hotel; Audubon Hospital; Louisville, KY (Diagnosis of Cardiovascular Disorders)

76. April 23-26, 1986; Ischia, Italy (Third International Conference on Human Tumor Markers)

77. May 15-18, 1986; Excelsior Hotel; University of Arkansas Medical School; Little Rock, AR

78. July 28-Aug 1, 1986; University of Occupational and Environmental Health, Kitakyushu, Japan (Third International Conference on Clinical Chemistry and Chemical Toxicology of Metals)

79. Nov 13-16, 1986; Colony Square Hotel; Emory University School of Medicine; Atlanta, GA (Nucleic Acid Probes and Monoclonal Antibodies in Human Disease)

80. May 14-17, 1987; The Charleston Place Hotel; Medical University of South Carolina; Charleston, SC

81. Aug 17-21, 1987; Odense University, Denmark (Symposium on Trace Elements in Human Health & Disease)

82. Aug 25-28, 1987; Omni Park Hotel, New York, NY (Fourth International Conference on Human Tumor Markers)

83. Nov 12-15, 1987; Lincoln Hotel, Tampa, FL (Applied Seminar on Analytical and Clinical Toxicology)

84. May 12-15, 1988; Newporter Resort; UCLA Medical School; Beckman Instruments; Newport Beach, CA

85. May 29-June 3, 1988; Brioni Hotel, Brioni, Yugoslavia (Symposium on Drugs in Competitive Athletics)

86. Sept 5-9, 1988; Hanasaari Centre, Helsinki, Finland (Fourth International Conference on the Metabolism and Toxicology of Nickel)

87. Sept 19-23, 1988; Stockholm, Sweden (Fifth International Conference on Human Tumor Markers)

88. Nov 10-13, 1988; Parkview-Hilton Hotel, Hartford, CT; University of Connecticut Medical School, Farmington, CT (Applied Seminar on Hematology)

89. May 11-14, 1989; Omni Hotel; University of Virginia Medical School; Charlottesville, VA

90. May 23-26, 1989; Miyako Hotel, Tokyo, Japan (Sixth International Conference on Human Tumor Markers)

91. November 16-19, 1989; Hershey Hotel, Philadelphia, PA (Applied Seminar on Laboratory Diagnosis of Liver Diseases)

92. May 10-13, 1990; Meridien Hotel; University of British Columbia Faculty of Medicine; Vancouver, BC, Canada

93. June 5-8, 1990; Hanasaari Centre, Espoo, Helsinki, Finland (Fourth International Symposium on Trace Elements in Health and Disease)

94. September 10-14, 1990; Hotel Rus, Kiev, Russia (Seventh International Conference on Human Tumor Markers)

95. November 7-11, 1990; Clarion Hotel; University of Cincinnati Medical School; Cincinnati, OH (The Laboratory Diagnosis of Disorders of the Fetus, Newborn, and Early Childhood)

96. May 8-12, 1991; Red Lion Hotel; University of Utah Medical School; Salt Lake City, UT

97. September 9-12,1991; Triaena Congress Centre, Athens, Greece (International Congress on Immunoenzymatic Techniques)

98. November 14-17, 1991; Omni Hotel, Jacksonville, FL (Six Major Advances in Laboratory Diagnosis and Clinical Applications)

99. May 13-17, 1992; Sheraton University Inn; Medical School of the State University of New York; Syracuse, NY

100. Sept 6-10, 1992; Vienna, Austria (Ninth International Conference on Human Tumor Markers)

101. Nov 11-15, 1992; Red Lion Resort; Sansum Medical Foundation; Santa Barbara, CA (Laboratory Diagnosis of Metabolic Disorders, Emphasizing Diabetes Mellitus)

102. May 12-16, 1993; Newport Islander Doubletree Hotel; Brown University Medical School; Newport, RI

103. Sept 6-10, 1993; Bonn, Germany (Tenth International Conference on Human Tumor Markers)

104. Nov 3-7, 1993; Hilton Hotel; Medical College of Ohio; Toledo, OH (Advances in the Laboratory Diagnosis of Cancer)

105. May 11-15, 1994; Lodge Alley Inn; Medical University of South Carolina; Charleston, SC

106. Nov 16-20, 1994; Holiday Inn Crowne Plaza; University of South Florida College of Medicine; Tampa, FL (Clinical Science of Ageing)

107. May 10-14, 1995; Houston Plaza Hilton Hotel; MD Anderson Cancer Center; University of Texas School of Medicine; Houston, TX

108. June 11-14, 1995; New York Hilton, New York, NY (Twelfth International Conference on Human Tumor Markers)

109. July 10-13, 1995; University of British Columbia, Vancouver, Canada (Fifth International Symposium on Toxicology & Clinical Chemistry of Metals)

110. Oct 25-29 1996; Holiday Inn Crowne Plaza, Redondo Beach, CA (Immunologic Techniques for Diagnosis, Transplantation, and Therapy)

111. May 1-5, 1996; Carolina Inn; University of North Carolina Medical School; Chapel Hill, NC

112. June 16-19, 1996; Shangri-La Hotel, Singapore (Thirteenth International Conference on Human Tumor Markers)

113. Oct 30 - Nov 3 1996; Seelbach Hotel; University of Louisville Medical School; Louisville, KY (Neurologic and Psychiatric Diseases: Molecular Basis and Diagnostic Approaches)

114. May 7-11, 1997; University Park Hotel; University of Utah School of Medicine; ARUP Laboratories; Salt Lake City, UT

115. November 5-9, 1997; Emory Conference Hotel; Emory University School of Medicine; Atlanta, GA (Laboratory Diagnosis of Infectious Diseases)

116. April 29 - May 3, 1998; Biltmore Hotel; Brown University School of Medicine; Providence, RI

117. October 21-23, 1998; Doubletree Hotel; Jefferson Medical College; Philadelphia, PA (Clinical Science in the New Millennium)

118. October 5-9, 1999; Fawcett Center Hotel; Ohio State University Medical School; Columbus, OH

119. Nov 3-7, 1999; Radisson Hotel La Jolla; University of California at San Diego; Scripps Research Institute; La Jolla, CA (Molecular and Clinical Immunology and Immunopathology)

120. May 17-20, 2000; Partridge Inn; Medical College of Georgia; Augusta, GA Hemoglobinopathies)

121. May 9-12, 2001; The Carolina Inn; The University of North Carolina School of Medicine; Chapel Hill, NC (Applications of Molecular Biology in Laboratory Diagnosis)

122. May 8-11, 2002; Hotel Monaco; The University of Utah School of Medicine; ARUP Laboratories, Salt Lake City, UT (Sports Medicine, Fitness Training, and Related Topics)

123. May 7-11, 2003; TradeWinds Resort, University of South Florida College of Medicine; University of Tampa, St Petersburg, FL (Metabolic Diseases)

124. May 12-16, 2004; Warwick Hotel; University of Texas College of Medicine; The M.D. Anderson Cancer Center; Houston, TX (Infectious Diseases and Pulmonary Pathology; Informatics in Pathology and Laboratory Medicine)

125. May 11-15, 2005; Somerset Inn; William Beaumont Hospital, Troy and Royal Oak, MI (Diagnostic Applications of Molecular Biology)

126. May 17-21, 2006; Amelia Island Plantation Resort and University of Florida Medical School, Amelia Island (Diseases of the Reproductive Organs; Prevention of Medical Errors)

127. May 16-20, 2007; Hershey Lodge Conference Center, Penn State University Medical School, Geisinger Medical Center, Hershey and Danville, PA (Workshop on Proteomics in Cancer Therapy)

128. May 14-18, 2008; Marina del Mar Hotel and UCLA Medical School, Los Angeles, CA (Symposium on Solid Organ Transplantation)

129. May 13-17 2009; Embassy Suites Hotel; University of South Florida College of Medicine and the University of Tampa, Tampa, FL

130. May 12-16, 2010; St Anthony Hotel; University of Texas Health Science Center, San Antonio, TX (Transfusion Medicine)

131. May 18-22, 2011; Seelbach Hilton Hotel; University of Louisville School of Medicine; Louisville KY (Personalized Medicine and Genomics)

Back to top

Association of Clinical Scientists

6431 Fannin, MSB2.292   |   Houston, TX 77030   |   USA

Phone: (713) 234-6387   |   Fax: (713) 344-1144   |   E-mail: clinsci@sover.net

© 2005-2010 Association of Clinical Scientists. All rights reserved.